Skip to main content
TipRanks
Go Ultimate75% OFF

Proteome Sciences (PI2) Stock Price & Analysis

0 Followers

PI2 Stock Chart & Stats

€0.03€0.02(230.00%)
At close: 2:00 AM GMT+2
€0.025€0.05€0.075€0.1Nov 18May 9May 28Sep 16Jun 10
Day’s Range
EUR 0.01 - EUR 0.03
52-Week Range
EUR 0.01 - EUR 0.04
Previous Close
EUR 0.01
Volume
N/A
Average Volume (3M)
327
Market Cap
EUR 5.72M
Enterprise Value
EUR 20.50M
Total Cash (Recent Filing)
EUR 1.10M
Total Debt (Recent Filing)
EUR 15.95M
Price to Earnings (P/E)
―
Beta
-4.85
Next Earnings
Apr 01, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Specialized Proteomics Offering

The company operates in a specialized proteomics niche that directly supports drug discovery and biomedical research. Its combination of analytical services, mass spectrometry workflows, and bioinformatics gives it a defined offering for pharmaceutical, biotechnology, and academic customers over the medium term.

Improved Cash Flow Trend

Cash consumption improved materially in 2025 compared with the prior year, reducing the immediate pace of funding required by operations. Although cash flow remains negative, this improvement could support greater financial control if maintained through further cost discipline and operating stabilization.

Positive Reported EPS Growth

The reported positive EPS growth indicates that per-share earnings performance improved relative to the comparison period, providing one constructive signal within otherwise weak results. Sustaining this improvement would help demonstrate progress toward reducing losses, although the company remains unprofitable overall.

Bears Say

Severe Solvency Pressure

The combination of rising debt, deeply negative equity, and assets below total debt indicates a capital structure under significant strain. This reduces financial flexibility and leaves the company more exposed to refinancing requirements, potential dilution, and constraints on funding its operating plans.

Declining Revenue And Gross Profit

Revenue contraction alongside a move to negative gross profit points to deteriorating commercial scale and weak cost absorption. If this pattern persists, the company will have less operating leverage to support its specialized activities, making a return to sustainable profitability more difficult.

Persistent Operating Losses

Large operating and net losses over multiple years demonstrate that the current business model is not covering its cost base. Persistent unprofitability limits internally generated funding, increases reliance on external capital, and weakens the company’s ability to absorb further revenue or margin pressure.

Proteome Sciences News

PI2 FAQ

What was Proteome Sciences’s price range in the past 12 months?
Proteome Sciences lowest stock price was €0.01 and its highest was €0.04 in the past 12 months.
What is Proteome Sciences’s market cap?
Proteome Sciences’s market cap is €5.72M.
When is Proteome Sciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Proteome Sciences’s earnings last quarter?
Proteome Sciences released its earnings results on Jul 23, 2026. The company reported -€0.005 earnings per share for the quarter.
Is Proteome Sciences overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Proteome Sciences pay dividends?
Proteome Sciences does not currently pay dividends.
What is Proteome Sciences’s EPS estimate?
Proteome Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Proteome Sciences have?
Proteome Sciences has 350,724,900 shares outstanding.
What happened to Proteome Sciences’s price movement after its last earnings report?
Proteome Sciences reported an EPS of -€0.005 in its last earnings report. Following the earnings report the stock price went down -7.143%.
Which hedge fund is a major shareholder of Proteome Sciences?
Currently, no hedge funds are holding shares in DE:PI2
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology